Private Advisor Group’s Carisma Therapeutics CARM Stock Holding History

Private Advisor Group’s Portfolio CARM Stock Details CARM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$6	–	1979
2022 Q4	$6	Hold	500	–	–	﹤0.01%	1662
2022 Q3	$4K	Hold	500	–	–	﹤0.01%	1899
2022 Q2	$8K	Hold	500	–	–	﹤0.01%	2096
2022 Q1	$6K	Hold	500	–	–	﹤0.01%	2084
2021 Q4	$8K	Hold	500	–	–	﹤0.01%	2127
2021 Q3	$8K	Sell	500 -51	-9%	-$2.45K	﹤0.01%	2011
2021 Q2	$51K	Sell	551 -124	-18%	-$7.91K	﹤0.01%	1935
2021 Q1	$35K	Sell	675 -2,025	-75%	-$95.5K	﹤0.01%	1861
2020 Q4	$73K	Hold	2,700	–	–	﹤0.01%	1708
2020 Q3	$76K	Buy	2,700 +1,000	+59%	+$20K	﹤0.01%	1502
2020 Q2	$24K	Hold	1,700	–	–	﹤0.01%	2473
2020 Q1	$19K	Hold	1,700	–	–	﹤0.01%	1394
2019 Q4	$35K	Buy	1,700 +750	+79%	+$17.2K	﹤0.01%	1596
2019 Q3	$22K	Hold	950	–	–	﹤0.01%	1632
2019 Q2	$29K	Sell	950 -1,971	-67%	-$59K	﹤0.01%	1640
2019 Q1	$60K	Buy	+2,921	New	+$50.4K	﹤0.01%	1507
2018 Q4	–	Sell	-1,226	Closed	-$53K	–	1383
2018 Q3	$53K	Buy	+1,226	New	+$47.8K	﹤0.01%	1561
2018 Q2	–	Sell	-976	Closed	-$21K	–	1312
2018 Q1	$21K	Buy	+976	New	+$18.7K	﹤0.01%	1140

Other funds holding CARM

TOTUOP

Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

Deuterium Capital Management Clearwater, Florida $86M AUM 87.31% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Private Advisor Group's CARM Position: Q1 2023 in Review

Private Advisor Group sold out of Carisma Therapeutics (CARM) in Q1 2023, closing a stake of 500 shares — an estimated $6 sold.

Private Advisor Group first reported a position in CARM in Q1 2018 and held it in 18 quarters. The position peaked at $76K in Q3 2020. 37 funds tracked by Wall St. Rank hold CARM as of Q1 2023.

Private Advisor Group reported no remaining Carisma Therapeutics position as of Q1 2023 after selling out during the quarter.
Private Advisor Group sold 500 Carisma Therapeutics shares in Q1 2023, an estimated $6.
Private Advisor Group first reported a position in Carisma Therapeutics in Q1 2018 and held it in 18 quarters.
Private Advisor Group's Carisma Therapeutics position peaked at $76K in Q3 2020.
37 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2023.

Based on Private Advisor Group's 13F filing for Q1 2023, filed 10 May 2023.